The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.

BACKGROUND: The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial aimed to determine whether or not oral Δ(9)-tetrahydrocannabinol (Δ(9)-THC) slowed the course of progressive multiple sclerosis (MS); evaluate safety of cannabinoid administration; and, improve methods for testin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Main Authors: Ball, Susan, Vickery, Jane, Hobart, Jeremy, Wright, Dave, Green, Colin, Shearer, James, Nunn, Andrew, Cano, Mayam Gomez, MacManus, David, Miller, David, Mallik, Shahrukh, Zajicek, John
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781163/
https://ncbi.nlm.nih.gov/pubmed/25676540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta19120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados